Seeking Alpha

More on Rite Aid's (RAD) FQ1: Same-store sales 2.5% higher Y/Y, with pharmacy sales up 2.4%...

More on Rite Aid's (RAD) FQ1: Same-store sales 2.5% higher Y/Y, with pharmacy sales up 2.4% impacted by Walgreen/Express Scripts dispute. SG&A expenses as a percentage of revenue rose to 26.1%, from 24.8% a year ago. Expects sales of $25.3B-$25.7B in FY13 and EPS to fall in a range of -$0.13 to -$0.29. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs